MeSH tree: C15.378.508
Patients with multiple myeloma (MM) have a distinct pattern of second primary malignancy (SPM), with a markedly increased risk of hematologic SPMs, according to a review published online April 6 in Frontiers in Oncology.
11 hours ago
0
3
A deadly form of leukemia may be stopped before it ever develops by introducing targeted maternal screening in the United States, according to new research. The national study, led by physician-scientists at Sylvester Comprehensive ...
17 hours ago
0
4
New research out of VCU Massey Comprehensive Cancer Center has uncovered a targeted cancer therapy that significantly prevents leukemia progression, improves survival rates and minimizes damage to surrounding healthy tissue.
19 hours ago
0
4
A genetic alteration that is already routinely analyzed in patients with acute myeloid leukemia can be used to identify patients who respond to a new targeted therapy, according to a study published in the journal Discover ...
Apr 29, 2026
0
2
A new way of using umbilical cord blood for treating blood diseases could make the treatment more accessible to patients who need a stem cell transplant. A Phase II clinical trial of patients undergoing a cord blood transplant ...
Apr 27, 2026
0
8
Early exposure to PFAS, a group of widely used compounds known as "forever chemicals," was associated with a higher risk of acute lymphoblastic leukemia, the most common childhood cancer, according to University of California, ...
Apr 27, 2026
0
6
Scientists have developed a strategy to boost the cancer-fighting power of natural killer (NK) cells, part of the immune system's first line of defense. NK cells can detect and destroy cancer cells, but tumors often create ...
Apr 27, 2026
0
8
A KAIST research team has identified the real reason why anticancer drugs kill cancer cells—targeted anticancer therapies do not simply block cancer proteins but rather shut down the "protein factories" inside the cells, ...
Apr 23, 2026
0
4
Leukemia is adept at dodging the immune system, making it resistant to many of the newest generation of cancer immunotherapies. Now, researchers have identified a key part of the cancer's disguise: a protein called CD43 on ...
Apr 10, 2026
0
8
Researchers have developed a new tool to help clinicians tailor personalized treatment plans for patients with a rare blood cancer called chronic myelomonocytic leukemia (CMML). The tool, called the international CMML Prognostic ...
Apr 9, 2026
0
5
